Northern Trust
NUVB icon

Northern Trust’s Nuvation Bio NUVB Stock Holding History

Northern Trust’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
2,321,873
+318,765
+16% +$1.56M ﹤0.01% 2044
2026
Q1 		$8.59M Buy
2,003,108
+81,376
+4% +$453K ﹤0.01% 2157
2025
Q4 		$17.2M Sell
1,921,732
-195,940
-9% -$1.21M ﹤0.01% 1769
2025
Q3 		$7.84M Buy
2,117,672
+33,505
+2% +$91.3K ﹤0.01% 2243
2025
Q2 		$4.06M Buy
2,084,167
+67,502
+3% +$141K ﹤0.01% 2578
2025
Q1 		$3.55M Sell
2,016,665
-70,086
-3% -$160K ﹤0.01% 2606
2024
Q4 		$5.55M Buy
2,086,751
+563,627
+37% +$1.45M ﹤0.01% 2451
2024
Q3 		$3.49M Buy
1,523,124
+255,809
+20% +$780K ﹤0.01% 2689
2024
Q2 		$3.7M Buy
1,267,315
+35,978
+3% +$110K ﹤0.01% 2564
2024
Q1 		$4.48M Buy
1,231,337
+11,100
+0.9% +$21.3K ﹤0.01% 2534
2023
Q4 		$1.84M Sell
1,220,237
-80,598
-6% -$104K ﹤0.01% 3037
2023
Q3 		$1.74M Buy
1,300,835
+49,301
+4% +$82.1K ﹤0.01% 3018
2023
Q2 		$2.25M Buy
1,251,534
+178,987
+17% +$304K ﹤0.01% 2941
2023
Q1 		$1.78M Buy
1,072,547
+5,024
+0.5% +$10.2K ﹤0.01% 2989
2022
Q4 		$2.05M Buy
1,067,523
+39,495
+4% +$79.9K ﹤0.01% 2981
2022
Q3 		$2.3M Sell
1,028,028
-8,266
-0.8% -$23.6K ﹤0.01% 2948
2022
Q2 		$3.36M Sell
1,036,294
-327,805
-24% -$1.43M ﹤0.01% 2762
2022
Q1 		$7.17M Sell
1,364,099
-51,347
-4% -$288K ﹤0.01% 2356
2021
Q4 		$12M Buy
1,415,446
+669,667
+90% +$6.15M ﹤0.01% 2110
2021
Q3 		$7.41M Buy
745,779
+265,917
+55% +$2.41M ﹤0.01% 2486
2021
Q2 		$4.47M Buy
479,862
+361,300
+305% +$4.12M ﹤0.01% 2904
2021
Q1 		$1.24M Buy
+118,562
New +$1.33M ﹤0.01% 3498

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Northern Trust's NUVB Position: Q2 2026 in Review

Northern Trust increased its Nuvation Bio (NUVB) stake by 16% in Q2 2026, buying an estimated $1.56M and bringing the position to 2,321,873 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

Northern Trust first reported a position in NUVB in Q1 2021 and has held it in 22 quarters since. The position peaked at $17.2M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Northern Trust held 2,321,873 shares of Nuvation Bio worth $13.2M as of Q2 2026.
  • Northern Trust bought 318,765 Nuvation Bio shares in Q2 2026, an estimated $1.56M.
  • Nuvation Bio made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2044 holding.
  • Northern Trust first reported a position in Nuvation Bio in Q1 2021 and has held it in 22 quarters since.
  • Northern Trust's Nuvation Bio position peaked at $17.2M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.